Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com started coverage on shares of Insulet (NASDAQ:PODD – Free Report) in a research note released on Thursday. The brokerage issued a hold rating on the medical instruments supplier’s stock. PODD has been the topic of several other reports. JPMorgan Chase & Co. cut their price objective on shares of Insulet from $365.00 to $325.00 […]
Triodos Investment Management BV reduced its holdings in Insulet Co. (NASDAQ:PODD – Free Report) by 20.0% during the 1st quarter, Holdings Channel reports. The firm owned 40,000 shares of the medical instruments supplier’s stock after selling 10,000 shares during the quarter. Triodos Investment Management BV’s holdings in Insulet were worth $12,758,000 at the end of […]
Clearstead Advisors LLC boosted its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 559.1% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 145 shares of the medical instruments supplier’s stock after purchasing an additional 123 shares during the quarter. Clearstead […]
Y Intercept Hong Kong Ltd cut its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 14.4% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,038 shares of the medical instruments supplier’s stock after selling 343 shares during the quarter. Y Intercept […]
California State Teachers Retirement System lowered its holdings in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 0.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 118,611 shares of the medical instruments supplier’s stock after selling 1,045 shares during the […]